Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.26 USD | -1.56% | -1.56% | +24.75% |
05-15 | Canaccord Genuity Trims Price Target on Passage Bio to $13 From $14, Maintains Buy Rating | MT |
03-04 | Passage Bio, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+24.75% | 77.67M | |
+9.99% | 115B | |
+12.01% | 106B | |
-3.07% | 24.69B | |
-0.93% | 21.97B | |
-5.43% | 19.27B | |
-6.90% | 17.56B | |
-39.36% | 17.32B | |
+5.82% | 14.03B | |
+33.05% | 12.13B |
- Stock Market
- Equities
- PASG Stock
- News Passage Bio, Inc.
- Transcript : Passage Bio, Inc. Presents at JPMorgan 40th Annual Healthcare Conference, Jan-10-2022 10